Prevalence, incidence and risk factors in Alzheimer's disease;Prévalence, incidence et facteurs de risque de la maladie D'Alzheimer

Gerontologie et Societe

Volumn 128-129, Issue 1-2, 2009, Pages 129-141

  Ankri, Joël ^a  

^a Versailles Saint Quentin en Yvelines University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349336582     PISSN: 01510193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and statistical Manual of Mental Disorders 3rd ed. 1987; 4th ed, 1994.
2. ANDERSEN K., LAUNER L.J., DEWEY M.E. et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999; 53: 1992-1997
3. ANKRI J. & POUPARD M. Prevalence and Incidence of dementia in the very elderly: a literature review. Rev Epidemiol Sante Publique 2003;51:349-360
4. BACHMAN D.L., WOLF P.A., LINN R.T. et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993; 43:515-519
5. BIRGE S.J. The role of oestrogen in the treatment of Alzheimer's disease. Neurology 1997; 48(suppl):S36-41.
6. BRAYNE C. The elephant in the room - healthy brains in later life, epidemiology and public health. Nat Rev Neurosci 2007;8(3):233-239
7. COMMENGES D., JOLY P., LETENNEUR L. & DARTIGUES JF. Incidence and mortality of Alzheimer's disease or dementia using an illness-death model. Stat Med 2004,23: 199-210.
8. DE LA TORRE J.C. Alzheimer disease as a Vascular disorder. Nosological evidence. Stroke 2002; 33:1152-1162
9. GUSTAFSON D. Adiposity indices and dementia. Lancet Neurol 2006;5(8):713-720
10. HACHINSKI V. Shifts in thinking about dementia. JAMA 2008;300(18):2172- 2173
11. HEBERT L.E., BECKETT L.A., SCHERR P.A. & EVANS D.A. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 2001; 15:169-73.
12. Int'Veld B.A., Ruintenberg A., Hofman A., et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001; 345:1515-1521.
13. JORM A.F. & JOLLEY D. The incidence of dementia: a meta-analysis. Neurology 1998; 51:728-733
14. LETENNEUR L., COMMENGES D., DARTIGUES J.F. & BARBERGER- GATEAU P. Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol 1994; 23:1256-1261
15. LOBO A., LAUNER L.J., FRATIGLIONI L. et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of populationbased cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54:S4-9. (Pubitemid 30390598)
16. MCKAHN G., DRACHMAN D., FOLSTEIN M.P.D. & STADLAN E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34:939-944
17. RAMAROSON H., HELMER C., BARBERGER-GATEAU P., LETENNEUR L. & DARTIGUES J.F. Prévalence de la démence et de la maladie dAlzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte Paquid. Rev Neurol2003; 159:405-11.
18. VON STRAUSS E., VITANEN M., DE RONCHI D. et al. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagerian. Arch Neurol 1999; 56:587-592
19. WHALLEY L.J., DICK F.D. & MCNEILL G. A life-course approach to the aetiology of late-onset dementias. Lancet Neurol 2006;5(1):87-96.